Filing Details

Accession Number:
0001415889-23-011884
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-08-04 21:35:09
Reporting Period:
2023-08-02
Accepted Time:
2023-08-04 21:35:09
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1604821 Natera Inc. NTRA Services-Medical Laboratories (8071) 010894487
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1646649 Jonathan Sheena C/O Natera, Inc.
13011 Mccallen Pass Building A Suite 100
Austin TX 78753
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2023-08-02 500 $44.15 23,655 No 4 S Indirect By Caraluna 1 Trust
Common Stock Disposition 2023-08-02 500 $44.15 23,655 No 4 S Indirect By Caraluna 2 Trust
Common Stock Disposition 2023-08-02 5,000 $44.22 504,746 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect By Caraluna 1 Trust
No 4 S Indirect By Caraluna 2 Trust
No 4 S Direct
Footnotes
  1. The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 13, 2023.
  2. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.85 to $44.60 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  3. Held for the benefit of the Reporting Person's minor children. The Reporting Person disclaims beneficial ownership over such securities.
  4. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.85 to $44.60 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  5. The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 13, 2022.
  6. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.91 to $44.60 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.